Trientine tetrahydrochloride - GMP-Orphan

Drug Profile

Trientine tetrahydrochloride - GMP-Orphan

Alternative Names: Cuprior; TETA 4HCl

Latest Information Update: 25 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GMP-Orphan SAS
  • Class Ethylenediamines; Small molecules
  • Mechanism of Action Chelating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hepatolenticular degeneration
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Hepatolenticular degeneration

Most Recent Events

  • 21 Apr 2017 Committee for Medicinal Products for Human Use (CHMP) of the EMA recommends approval of Trientine tetrahydrochloride for Wilson's disease in European Union
  • 12 Apr 2017 Phase-III clinical trials in Wilson's disease in Austria (PO) (EudraCT2016-003876-29 )
  • 27 Oct 2016 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top